投稿注册咨询:400-008-5413 销售咨询:010-6029 9110、80259978
Surapon Nochaiwong:Proton Pump Inhibitors Use Is Not Associated with Peritoneal Dialysis-Related Peritonitis: A Propensity Score Analysis PPT讲座视频 The 8th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD 2017)
标题: Proton Pump Inhibitors Use Is Not Associated with Peritoneal Dialysis-Related Peritonitis: A Propensity Score Analysis
讲者: Surapon Nochaiwong
单位: Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University 2) Pharmacoepidemiology and Statistics Clinics, Faculty of Pharmacy, Chiang Mai University
播放: 1652
论文摘要: Background Proton pump inhibitors (PPIs) suppress gastric acid secretion, allow bacterial colonization, and may cause intestinal bacterial overgrowth and translocation. To date, evidences have yielded inconsistent findings about the association between PPIs use and the risk of peritoneal dialysis (PD)-related peritonitis.
Objectives To investigate whether PPIs use is associated with an increased risk for PD-related peritonitis.
Methods We conducted a retrospective cohort study using the PD registry database at Kidney center, General Hospital, Chiang Mai, Thailand. Subjects were first-ever PD treatment for > 90 days, between January 2008, and December, 2014 with follow-up through December 2015. The cohort included patients aged > 18 years who started a new episode of PPIs use for > 90 days. To control for demographics comorbidities, and other potential-confounders, propensity score-adjusted and multivariable Cox proportional hazards were used to evaluate the association of PPIs use with time to first PD-related peritonitis.
Results The cohort comprised 411 PD patients, 70 (17.0%) were PPIs users. At entry, PPIs users had more history of gastrointestinal diseases in comparison with non-PPIs users. Patient were followed for a median of 18.0 months. Over half of patients, 235 (57.2%), were identified as having the first episode of PD-related peritonitis. Compared to non-PPIs users, PPIs users was not associated with a higher risk for PD-related peritonitis (propensity adjusted hazard ratio [HR] = 1.22; 95% confidence interval [CI], 0.82-1.82; P=0.332). Likewise, multivariable Cox proportional hazards regression yielded similar results (adjusted HR=1.48; 95% CI, 0.97-2.27; P=0.071). In a subgroup analysis, we did not find any effect modification by causative organisms of PD-related peritonitis.
Conclusions After adjustment for detailed clinical factors, PPIs use had a neutral association with PD-related peritonitis under most circumstances. On the basis of safety and possible concerns in specific clinical situations, a large pragmatic trials of gastric acid suppressants are needed.
 

Department of Pharmaceutical Care

Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University 2) Pharmacoepidemiology and Statistics Clinics, Faculty of Pharmacy, Chiang Mai University

该讲者其他视频
相关视频
该讲者其他论文

l Proton Pump Inhibitors Use Is Not Associated with Peritoneal Dialysis-Related Peritonitis: A Propensity Score Analysis

作者: Surapon Nochaiwong

单位: Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University 2) Pharmacoepidemiology and Statistics Clinics, Faculty of Pharmacy, Chiang Mai University

来源: The 8th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD 2017)

相关论文
学术交流区 (0条留言)
最新留言
产品&服务
• 学会/协会管理系统
• 会务通学术会议服务平台
• 现场注册签到管理系统
• 会场幻灯传输转播系统
• 学术会议网络直播系统
• E-Poster电子壁报系统
• 企业数字助展服务
• 花生会议管理系统
帮助中心
• 功能更新
• 常见问题
关于我们
• 公司简介
• 版权声明
• 联系我们
微信扫描
美迪康官方微信
Copyright©2007-2017 MEDCON. All Rights Reserved.北京美迪康信息咨询有限公司 版权所有. 京ICP备11011505号-31 京公网安备 11011502002826号